Closed now
Closed now
At MUSC Health's Hollings Cancer Center, our team of more than 30 head and neck cancer specialists prides itself on offering you innovative care. They work together, bringing in multiple layers of expertise. And we dont just rely on existing treatments - our team is constantly searching for new, better ways to meet your needs.
Dr. Emily Rosenberg is a distinguished endocrinologist recognized for her expertise in endocrine disorders during pregnancy. She earned a Bachelor of Arts in Psychology from the University of Pennsylvania and a Doctor of Medicine (M.D.) degree from the Pennsylvania State College of Medicine. She completed her internal medicine residency at Beth Israel Deaconess Medical Center and fellowship in endocrinology at Brigham and Women's Hospital in Boston, MA. After completing the fellowship, she was on faculty at Brigham and Women's Hospital before transitioning to her current role as an assistant professor in medicine at the Medical University of South Carolina.Dr. Rosenberg's research interests include evaluating the impact of dietary macronutrients on glucose in pregnancy, and she has published her work in esteemed journals as well as presented her work at national meetings. She is board-certified in Internal Medicine and Endocrinology, Diabetes, and Metabolism, excelling in inpatient and outpatient settings.Dr. Rosenberg is a respected endocrinologist known for her dedication to advancing our understanding of endocrine disorders, her commitment to patient care, and her passion for medical education.
Closed now
Dr. Sharma is the Donald O. Castell Endowed Chair in Gastroenterology at the Medical University of South Carolina (MUSC) with a clinical and translational focus in Neurogastroenterology & Motility (NGM), particularly diabetic gastroparesis and Parkinsons disease. He obtained his medical degree at Virginia Commonwealth University, completed internal medicine residency at Temple University Hospitals, and GI fellowship at Penn State Hershey Medical Center. Dr. Sharmas research focus is understanding the pathophysiology of gut-brain axis in various conditions and developing innovative, non-invasive, and promising neuromodulation therapies through his insights, outstanding mentorship and collaborations, and his engineering background. He currently serves as principal investigator of a NIH-funded multi-center, randomized, sham-controlled study investigating thoracic neuromodulation for diabetic gastroparesis (R01-DK133520) and one of the multiple PIs of one of the 5 centers in the NIDDK-supported Gut-Brain Parkinsons Disease Consortium (GBPDC) (U01-DK140923).
